Physician profile
Jina Chung
NPI 1558450668
$3,490.31
in general payments reported to CMS, 2019-2025
21 companies · $510 in 2025
The $510 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $299 · 2021: $327 · 2022: $375 · 2023: $379 · 2024: $773 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,006.73 | 2019-2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $358.45 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $314.87 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $314.06 | 2019-2025 | |
| Heartflow, INC. | $222.82 | 2025 | |
| Amgen INC. | $180.37 | 2019-2021 | |
| Abbott Laboratories | $177.45 | 2019-2022 | |
| Medtronic Vascular, INC. | $167.40 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $118.29 | 2019-2021 | |
| Astellas Pharma US INC | $117.14 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $111.72 | 2024-2025 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $52.66 | 2024 | Arcalyst |
| Boston Scientific Corporation | $49.47 | 2021-2023 | Avvigo Guidance System |
| Chiesi USA, INC. | $48.55 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $44.57 | 2020-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $43.07 | 2024 | |
| United Therapeutics Corporation | $42.21 | 2023 | Tyvaso |
| E.R. Squibb & Sons, L.L.C. | $40.86 | 2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.53 | 2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $26.14 | 2024 | |
| Alnylam Pharmaceuticals INC. | $19.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jina Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.